Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease Patients

NCT06115421 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Anemia in Dialysis-dependent CKD Patients

Interventions

DRUG: Roxadustat

Sponsor

Alexandria University